Wegovy is a brand name for semaglutide, a prescription medicine used for ongoing weight management. In Australia, it's approved for eligible adults and adolescents as part of a broader plan that also includes healthy eating and regular physical activity. A doctor decides whether it's suitable based on factors like age, body mass index (BMI), medical history and any weight-related health conditions.
Wegovy belongs to a class of medicines called GLP-1 receptor agonists. It mimics a natural hormone involved in appetite and blood sugar control, which can help a person feel fuller and less hungry. It's given as a weekly injection, with the dose usually increased gradually.
Common side effects include nausea, vomiting, diarrhoea, constipation and stomach discomfort, and more serious side effects are possible. It isn't suitable for everyone, so a doctor should review other medicines, pregnancy plans and any upcoming surgery beforehand. Weight loss isn't guaranteed, and regular follow-up helps track progress and side effects.
Book a telehealth consultation with an AHPRA-registered GP for assessment, prescriptions, referrals or advice.
Book ConsultationWegovy is a brand of the prescription medicine semaglutide, approved in Australia to help with long-term weight management in eligible people.
No. This glossary explains general health terminology, not your individual symptoms or test results. Speak with a qualified health professional for advice about your circumstances. For a medical emergency, call 000.
Proudly Australian-owned and operated